You are here

Clinical Trials: Cord Blood

Conditions:   Hematopoietic Stem Cell Transplantation;   Malignant Hematological Diseases
Intervention:   Procedure: Umbilical Cord Blood Transplantation
Sponsor:   The First Affiliated Hospital of Soochow University
Conditions:   Acute Myelogenous Leukemia (AML);   Acute Lymphoblastic Leukemia (ALL);   Chronic Myelogenous Leukemia (CML);   Myelodysplastic Syndromes (MDS);   Myeloproliferative Disorder;   Non-Hodgkin's Lymphoma
Interventions:   Drug: Conditioning Chemotherapy;   Biological: Cord blood graft
Sponsor:   Memorial Sloan Kettering Cancer Center
Condition:   Umbilical Cord Blood
Interventions:   Procedure: Ex-utero cord blood collection;   Procedure: In-utero cord blood collection
Sponsor:   Institut Universitari Dexeus
Not yet recruiting
Condition:   Bone Marrow Failure Disorders
Interventions:   Drug: Cyclosporine A;   Biological: Umbilical cord blood & Umbilical cord derived mesenchymal stem cells
Sponsors:   Shandong Qilu Stem Cells Engineering Co., Ltd.;   Shandong Third Provincial Hospital;   Dezhou People's Hospital;   Qilu Children's Hospital of Shandong University;   The Second Affiliated Hospital of Shandong First Medical University;   Tai'an Central Hospital;   Linyi People's Hospital;   Linyi Central Hospital;   Rizhao People's Hospital;   Lanling People's Hospital;   Shandong Jining No.1 People's Hospital;   The affiliated hospital of Jining medical college;   Zibo municipal hospital;   Binzhou People's Hospital;   The Affiliated Hospital of Binzhou Medical College;   Shengli Oilfield Central Hospital;   Weihai Municipal Hospital;   Weihai Central Hospital;   The Second Affiliated Hospital of Shandong University of traditional Chinese Medicine;   Gansu Provincial Hospital of Traditional Chinese Medicine (TCM);   Wuwei People's Hospital;   Gansu Wuwei Tumour Hospital;   The Second Affiliated Hospital of Harbin Medical University;   Yuncheng Institute of Hematology;   Kaifeng Central Hospital;   Zhengzhou Central Hospital;   Air Force Hospital of Western War Zone;   The First People' s Hospital of Yunnan Province;   Zigong No.1 Peoples Hospital;   The First People's Hospital of Jingzhou;   Jiangxi Province Children's Hospital
Not yet recruiting
Condition:   Graft Vs Host Disease
Intervention:   Drug: Cyclophosphamide
Sponsor:   Centro de Hematología y Medicina Interna
Enrolling by invitation
Conditions:   Bone Marrow Transplant;   Stem Cell Transplant
Intervention:   Drug: Zoster Vaccine Recombinant
Sponsors:   University of Colorado, Denver;   GlaxoSmithKline
Not yet recruiting
Condition:   Spinal Cord Injury, Acute
Interventions:   Biological: Multiple systemic (i.v.) administration of allogenic non-related group- and rhesus-compatible mononuclear cord blood cells;   Other: Control vehicle (sterile saline)
Sponsors:   Sklifosovsky Institute of Emergency Care;   State-Financed Health Facility "Samara Regional Medical Center Dinasty";   K.L. Hetagurov North-Osetian State University
Condition:   Poor Graft Function
Interventions:   Drug: decitabine;   Biological: umbilical cord blood;   Drug: Granulocyte-colony stimulating factor;   Drug: Recombinant human thrombopoietin / thrombopoietin receptor agonist;   Drug: Recombinant human erythropoietin
Sponsor:   The First Affiliated Hospital of Soochow University
Not yet recruiting
Conditions:   Myelodysplastic Syndromes;   Chronic Myelomonocytic Leukemia-2;   Secondary Acute Myeloid Leukemia
Intervention:   Drug: unrelated umbilical cord blood
Sponsor:   The First Affiliated Hospital with Nanjing Medical University
Condition:   UCB (Cord Blood) Microtransplantation in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
Intervention:   Combination Product: Basic chemotherapy + UCB transplantation
Sponsor:   Zhongnan Hospital